CRH and coronary artery disorder: Therefore, LXNX formula’s mechanism of treating CHD and co-morbid diseases and symptoms could be as such: LXNX formula acts upon CRH, and then influences the HPA axis through GPCRs signaling transduction pathway related to CRHR1 and POMC.